# HCV + to HCV - Kidney Transplant

> **NCT04320290** · PHASE4 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Kidney Failure
- Hepatitis C

## Interventions

- **DRUG:** Direct Acting Antivirals

## Key facts

- **NCT ID:** NCT04320290
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05-21
- **Primary completion:** 2020-06-16
- **Final completion:** 2020-06-16
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** New Related Protocol to be submitted
- **Last updated:** 2022-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04320290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04320290, "HCV + to HCV - Kidney Transplant". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04320290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*